Biologics Travel 2026: Humira, Enbrel, Cosentyx, Stelara Refrigeration, Customs, and Biosimilar Cost Arbitrage
Wellness Travel·11 min read·May 6, 2026

Biologics Travel 2026: Humira, Enbrel, Cosentyx, Stelara Refrigeration, Customs, and Biosimilar Cost Arbitrage

Biologics Travel 2026: Humira, Enbrel, Cosentyx, Stelara Refrigeration, Customs, and Biosimilar Cost Arbitrage

Your rheumatologist prescribed Humira and the first injection cost your insurance $8,400 with $1,800 coming out of your annual deductible. You learned the FDA approved 10 adalimumab biosimilars by 2024, with 6 designated interchangeable as of May 2025, and Yusimry comes in at $639 per prescription compared to Humira's $7,000-$9,000 list price. You read that the TSA exempts freezer packs from the 3-1-1 liquids rule when carrying refrigerated medication, but you cannot tell whether your Humira pen will survive the 14-hour flight to Singapore in your carry-on cooler. You read that Humira and Enbrel can survive 14 days at room temperature up to 77°F (25°C), but Cosentyx is only good for 4 days at 86°F (30°C), and you don't know how to plan a 21-day Asia trip around either tolerance window. Your psoriatic arthritis cousin in New Zealand told you about a US patient who tried to bring a year's supply of Humira through customs at Auckland and the inspector initially said "no" despite the prescription. You don't know what cold-chain travel cases actually work, what the customs documentation needs to look like, or whether the biosimilar cost gap makes domestic switching the smarter move than international travel logistics.

This guide gives you the actual 2026 biologics international travel landscape. Real refrigeration windows. Real biosimilar cost gaps. Real cold-chain travel kit requirements. Real customs framework. Travel Anywhere is the AI-powered travel planning platform at travelanywhere.chat that helps biologic patients plan trips around cold-chain logistics, research destination pharmacy access, and avoid the customs scenarios that complicate complex-medication travel.

TL;DR: Biologic medications including Humira (adalimumab), Enbrel (etanercept), Cosentyx (secukinumab), Stelara (ustekinumab), and Skyrizi (risankizumab) require refrigeration 36-46°F (2-8°C) for long-term storage. Critical room-temperature windows: Humira and Enbrel survive up to 14 days at 77°F (25°C) out of light; Cosentyx tolerates up to 4 days at 86°F (30°C). TSA exempts cold packs and gel packs from the 3-1-1 liquids rule for refrigerated medication. Carry biologics in carry-on, never checked. The US biologic market changed dramatically in 2023-2025: 10 FDA-approved Humira biosimilars with 6 designated interchangeable as of May 2025 (Simlandi, Yuflyma, Hadlima, etc.), with biosimilar pricing as low as $639 (Yusimry) vs Humira's $7K-$9K list. Stelara biosimilars also gained interchangeable approval in May 2025. International customs: carry physician letter, original packaging, prescription, and personal-use supply (typically 30-90 days). Cross-border refill is generally not feasible because biologics require physician supervision, prior authorization, and pharmacy infrastructure for cold storage.

Key Takeaways

  • Biologic medications must be refrigerated at 36-46°F (2-8°C) for long-term storage. Room-temperature tolerance windows differ by drug: Humira and Enbrel can be kept at up to 77°F (25°C) for 14 days out of light; Cosentyx tolerates up to 86°F (30°C) for 4 days; Stelara, Skyrizi, and other biologics have product-specific room-temp windows that should be verified on the package insert (source: AbbVie Humira Storage Guidelines, Amgen Enbrel Storage, Novartis Cosentyx Storage).
  • TSA exempts cold packs, gel packs, and freezer packs from the 3-1-1 liquids rule when carrying refrigerated medication. Notify the TSA officer at security; the medication and cooling supplies can be screened separately. TSA Cares (1-855-787-2227) can be called in advance for travelers with complex medication needs (source: TSA medication policy, 4allFamily Humira Travel Cases).
  • Always carry biologics in carry-on, NEVER checked luggage. Lost checked bags + biologic supply = expensive disaster. Use insulin-style travel cases with gel packs (Frio, 4allFamily, Vivi Cap brands). Many premium kits maintain the 36-46°F window for 24-48 hours.
  • The US biologic market transformed in 2023-2025. Humira market exclusivity ended January 2023. By 2024, 10 FDA-approved adalimumab biosimilars were available. By May 2025, 6 biosimilars are designated interchangeable (Simlandi, Yuflyma, Hadlima, etc.) meaning pharmacists can substitute without physician re-prescription. Pricing range: $639 per prescription (Yusimry) to $2,655 (Amjevita) vs Humira $7K-$9K list price (source: FDA Biosimilar Product Information, Pharmacy Times May 2025).
  • Stelara (ustekinumab) gained biosimilar interchangeability in May 2025. Multiple Stelara biosimilars are now available with similar 50-80% cost gaps. The biosimilar landscape now applies to a broader set of biologic medications than just Humira (source: Venable BiologicsHQ May 2025 Stelara approvals).
  • International customs documentation is critical. Carry physician letter (diagnosis, generic and brand name, dosage, supply quantity, prescription number), original packaging with intact label, prescription, and travel within personal-use supply (30-90 days typical). Cross-border biologic refill is generally NOT feasible because biologics require physician supervision, prior authorization, and cold-chain pharmacy infrastructure. Plan trips around supply windows and refill at home.

ADHD medication travel 2026: Adderall, Vyvanse country-by-country

What Are the Actual Refrigeration Tolerance Windows?

The single most important pre-trip data point for biologic patients is the room-temperature tolerance window for their specific medication. The numbers vary substantially.

Person pouring white pills from bottle into hand Photo by Harrison Cohen on Unsplash

Humira (adalimumab):

"Humira needs to be refrigerated between 36°F and 46°F (2°C and 8°C) and protected from light before first use. If kept at or below 77°F (25°C) and out of the light, Humira can be kept unrefrigerated for up to 14 days. After 14 days at room temperature, the medication must be discarded if not used."

Source: AbbVie Humira Storage and Handling Guidelines.

Enbrel (etanercept):

Same framework as Humira: 36-46°F long-term, up to 14 days at 77°F (25°C) out of light. After 14 days at room temperature, discard if unused.

Cosentyx (secukinumab):

Cosentyx has a more permissive room-temp window in temperature but a shorter time tolerance: up to 86°F (30°C) for 4 days. After 4 days at room temperature (or shorter at higher temperatures), discard if unused.

Stelara (ustekinumab):

Verify the current package insert for Stelara's room-temp window; the standard guidance is 36-46°F for long-term storage with limited room-temperature excursion.

Skyrizi (risankizumab):

Skyrizi follows similar 36-46°F refrigeration with product-specific room-temp guidance; verify the current package insert.

Other biologics:

Rituximab (Rituxan), tocilizumab (Actemra), abatacept (Orencia), ixekizumab (Taltz), guselkumab (Tremfya), and other biologics have product-specific storage requirements. Always verify against the package insert and the manufacturer's most current storage guidance before any trip.

Trip planning implication:

For Humira/Enbrel patients, a 10-14 day trip to a moderate climate is feasible without active refrigeration if the medication stays out of light. For Cosentyx patients, only short trips (under 4 days) work without active refrigeration, or active cooling is essential. For trips to hot climates (Southeast Asia, Middle East, Mexico in summer), active cooling via gel-pack cases is essential for any biologic.

What Are the TSA and Airport Rules?

TSA has explicit accommodations for refrigerated medications, but enforcement varies by airport and individual TSA officer.

Hand holding white pills spilling from bottle Photo by Harrison Cohen on Unsplash

The general framework:

  • Medication itself: TSA accepts prescription medications in carry-on, no quantity limit (within reason for personal use)
  • Cold packs and gel packs: exempt from the 3-1-1 liquids rule when carrying refrigerated medication
  • Documentation: not strictly required by TSA, but strongly recommended (physician letter, prescription)
  • Notification: tell the TSA officer at the start of screening that you have refrigerated medication and cooling supplies

TSA Cares (1-855-787-2227):

This dedicated line allows travelers with medical needs to call 72 hours in advance and arrange for TSA assistance through screening. For first-time international biologic travelers, TSA Cares is worth the call.

International airport screening:

Other countries' airport security generally accepts the same framework, but local rules vary. Frankfurt (FRA), Heathrow (LHR), Schiphol (AMS), Singapore Changi (SIN), and Hong Kong (HKG) all have well-established biologic medication accommodations. Smaller and developing-world airports may have less consistent procedures; allow extra time and carry more documentation.

Cooling supply for international flights:

Long-haul flights (8-15 hours) require travel cases with sustained cooling. Frio insulin cases (water-activated, no batteries), 4allFamily reusable gel-pack cases, and Vivi Cap mechanical cooling cases are the established product categories. For Cosentyx specifically (4-day room-temp window), active cooling is essential for any flight longer than a few hours.

How Much Does Biosimilar Substitution Save?

The Humira biosimilar story is one of the largest pharmaceutical pricing shifts in US history, and most patients have not yet captured the savings.

The pre-2023 baseline:

Humira list price ran $7,000-$9,000 per 30-day supply for years, generating roughly $20 billion in annual US revenue for AbbVie at peak. The high pricing reflected market exclusivity and the absence of generic-equivalent competition.

The 2023-2025 transformation:

"Market exclusivity for Humira ended in January 2023, when the first biosimilar medication, adalimumab-atto (Amjevita), became available. Since then, a total of 10 FDA-approved adalimumab biosimilars have launched in the market, some with pricing discounts 90% lower than Humira."

Source: FDA Biosimilar Product Information, Pharmacy Times May 2025 Interchangeability Update.

The current biosimilar landscape (May 2025):

  • 10 FDA-approved adalimumab biosimilars total
  • 6 designated interchangeable as of May 2025 (Simlandi, Yuflyma, Hadlima, etc.)
  • Pricing range: Yusimry $639 per prescription (cheapest), Amjevita $2,655 (premium)
  • Major PBM coverage shift: large pharmacy benefit managers announced moves to fully exclude Humira brand by July 2025

Practical patient action:

If you are still on brand Humira in 2026 and your insurance is not enforcing biosimilar substitution, ask your prescriber and pharmacist about switching to a biosimilar. The 50-90% cost gap can substantially reduce annual out-of-pocket costs, particularly for patients in high-deductible plans. Interchangeable designation means pharmacists can substitute without physician re-prescription.

Stelara biosimilars (also May 2025):

The same dynamic now applies to Stelara (ustekinumab). The May 2025 FDA interchangeable approvals for Stelara biosimilars created a similar 50-80% cost-saving opportunity for patients on ustekinumab for psoriasis, Crohn's disease, or ulcerative colitis.

Why Is Cross-Border Biologic Refill Generally Not Feasible?

Unlike ADHD medications (where Thailand or Mexico can serve as cost-arbitrage refill destinations) or HRT (where pharmacy-direct purchase is common in some countries), biologic medications have structural barriers to international refill that make cost arbitrage harder.

a bottle filled with pills sitting on top of a wooden table Photo by Bruno Guerrero on Unsplash

The barriers:

  1. Physician supervision required. Biologics require ongoing rheumatologist, dermatologist, or gastroenterologist management. Lab monitoring (TB testing, liver function, hepatitis screening) is required at intervals.
  2. Prior authorization documentation. Most biologics require step-therapy and prior authorization documentation that doesn't transfer internationally.
  3. Cold-chain pharmacy infrastructure. Most international pharmacies are not set up for cold-chain dispensing of biologics.
  4. High medication cost even abroad. Unlike Humira's pre-biosimilar US pricing, biologics in most international markets are still expensive ($1,500-$4,000 per 30-day supply in many EU and Asian markets), so the cost arbitrage is often smaller than for ADHD medications or HRT.
  5. Customs scrutiny. Biologics in injectable form attract more customs questions than oral medications.

Where international biologic supply might make sense:

  • Patients spending extended time abroad (3+ months) who can establish in-country physician care
  • Patients with EU residency who can access EU pharmacy systems with local prescription
  • Patients in countries with strong biosimilar markets (Germany, India, Brazil have early and aggressive biosimilar adoption)
  • Patients enrolled in clinical trials abroad that include the medication

For most US biologic patients in 2026, the better play is switching to a US biosimilar (Yusimry, Amjevita, Simlandi, etc.) rather than international travel for refill. The 50-90% cost gap from biosimilar substitution generally exceeds the savings from international refill, with none of the customs and cold-chain travel complexity.

How Should You Pack Cold-Chain Medication for International Travel?

The travel-kit infrastructure for refrigerated medication is well-developed, with several proven product categories.

blue and white tablet in container Photo by Pawel Czerwinski on Unsplash

Insulin-case style cooling kits:

  • Frio cases (water-activated, no batteries, sustain cooling for 24-48 hours when re-wetted)
  • 4allFamily reusable gel-pack cases (require pre-freezing, sustain cooling 12-24 hours)
  • Vivi Cap mechanical cooling cases (battery-operated active cooling, sustain longer)

Travel case selection by trip length:

  • Short trips (under 4 days): Frio case or gel-pack reusable
  • Medium trips (4-14 days): Combination of Frio (carry-on segment) and refrigeration at destination
  • Long trips (14+ days): Active refrigeration access at destination essential; consider biosimilar switch + supply timing rather than international transport

Pre-trip checklist:

  • Verify the package-insert room-temp window for your specific biologic
  • Test the travel case at home for at least 24 hours
  • Pack 25% extra supply beyond expected need
  • Pack medication in carry-on with documentation
  • Pre-freeze gel packs the night before travel
  • Bring backup gel packs that you can re-freeze at hotel
  • Have destination pharmacy contact information for emergency supply (rarely possible but worth knowing)

HRT and testosterone travel 2026: refills, customs, country pharmacy access covers the parallel framework for HRT/TRT, where pharmacy-direct purchase abroad is more feasible than for biologics. Medical tourism insurance complications coverage comparison is the relevant adjacent guide for emergency medical events while traveling on biologics.

What Customs Documentation Do You Actually Need?

The international customs framework for biologics is similar to other prescription medications but with cold-chain considerations.

a bottle of pills sitting on top of a pink surface Photo by Beelith USA on Unsplash

Always carry:

  • Physician letter on letterhead: diagnosis (rheumatoid arthritis, psoriasis, Crohn's, etc.), generic and brand name (e.g., adalimumab/Humira, etanercept/Enbrel), dosage and supply quantity, prescription number, prescribing physician contact, statement of medical necessity
  • Original pharmacy packaging with intact label
  • Prescription (paper or printed e-prescription)
  • Personal-use supply within country-specific allowance (typically 30-90 days)
  • Cooling supplies with you in carry-on

Country-specific notes:

  • EU: generally permissive for personal-use supply with documentation
  • UK: prescription required; personal-use supply with documentation OK
  • Australia/New Zealand: can have stricter customs; one documented case of inspector initially refusing despite valid prescription
  • Japan: less restrictive than for controlled substances; biologics with documentation generally OK
  • UAE/Singapore: verify with embassy in advance; documentation requirements similar to controlled substances
  • Mexico/Canada: generally permissive with documentation

Travel Anywhere is the AI-powered travel planning platform at travelanywhere.chat that helps biologic patients plan trip duration around medication supply windows, research destination cold-chain logistics (refrigerator-equipped accommodation, hotel coolers, partnership with destination pharmacies if needed), and avoid the cold-chain failures that can wreck a trip.

FAQ: Biologics International Travel 2026

Can I take my Humira pen out of the fridge for a 10-hour flight?

Yes, Humira tolerates room temperature up to 77°F (25°C) for up to 14 days out of light. A 10-hour flight is well within tolerance. Use a Frio case or insulated cooling kit for additional protection, and avoid leaving the medication in direct sunlight at the destination.

What about Cosentyx? Same rules?

No. Cosentyx has a different room-temp window: up to 86°F (30°C) for 4 days only. For Cosentyx, plan more carefully and use active cooling on long trips. The shorter room-temp tolerance means trips longer than 4 days require destination refrigeration access.

Will the TSA give me trouble for my gel packs?

Generally no. TSA's published policy exempts cold packs and gel packs from the 3-1-1 liquids rule when used to keep medication refrigerated. Notify the TSA officer at security. If you anticipate complications (very long flight, unusual cooling kit), call TSA Cares at 1-855-787-2227 in advance.

Can I get my Humira refilled at a pharmacy in London or Paris?

Generally not feasible without local physician engagement. EU pharmacies require local prescriptions for biologics, and biologics require ongoing physician supervision (lab monitoring, dose adjustments). For trips longer than your supply allows, plan to either switch trip dates or coordinate with a UK/EU rheumatologist for in-country prescription.

Should I switch to a Humira biosimilar?

For most patients in 2026, yes. With 6 interchangeable Humira biosimilars (May 2025), 90% cost reduction available (Yusimry $639/month vs $7K-$9K Humira), and major PBMs aggressively excluding brand Humira, the savings are substantial. Discuss with your rheumatologist or dermatologist; the interchangeable designation means pharmacist substitution requires no physician re-prescription.

Are biosimilars equally effective?

Yes, by FDA definition. Interchangeable biosimilars are required to demonstrate equivalent clinical efficacy and safety to the reference product. Real-world data from the 2023-2025 biosimilar adoption period continues to confirm equivalence. The "biosimilar versus brand" question is largely a price and pharmacy supply question, not a clinical outcome question.

What if my refrigerated medication accidentally freezes?

Discard it. Most biologics are damaged by freezing and should not be used. Discard frozen medication, contact your physician for emergency supply replacement, and adjust your cold-pack strategy (gel packs that are too cold or direct contact with frozen packs can cause freezing).

Sources

Ready to make this trip happen? Travel Anywhere plans and books everything — start to finish. Begin at travelanywhere.chat.

Rachel Caldwell

Rachel Caldwell — Editorial Director, TravelAnywhere

Rachel Caldwell is the Editorial Director of TravelAnywhere. She leads the editorial team behind every guide on travelanywhere.blog, focusing on primary research, honest budget math, and recommendations the team would book themselves. Last reviewed May 6, 2026.